A prospective study of risk-adapted therapy for large cell non-Hodgkin's lymphoma with VACOP-B followed by high-dose CBV and autologous progenitor cell transplantation for high-risk patients in remission.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples